KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.25 $5.20 Friday, 26th Apr 2024 AVXL stock ended at $3.44. This is 1.47% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.07% from a day low at $3.38 to a day high of $3.48.
90 days $3.25 $6.82
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Mar 07, 2016 $4.45 $4.72 $4.40 $4.61 506 400
Mar 04, 2016 $4.89 $4.90 $4.36 $4.47 765 200
Mar 03, 2016 $4.60 $4.91 $4.54 $4.80 506 000
Mar 02, 2016 $4.46 $4.70 $4.41 $4.63 427 900
Mar 01, 2016 $4.45 $4.59 $4.37 $4.55 342 100
Feb 29, 2016 $4.50 $4.62 $4.30 $4.47 436 600
Feb 26, 2016 $4.50 $4.52 $4.32 $4.44 295 300
Feb 25, 2016 $4.16 $4.50 $4.15 $4.40 591 600
Feb 24, 2016 $3.89 $4.28 $3.83 $4.24 444 300
Feb 23, 2016 $3.93 $4.07 $3.92 $4.05 260 100
Feb 22, 2016 $3.95 $4.13 $3.80 $4.03 491 200
Feb 19, 2016 $4.25 $4.26 $3.85 $3.98 726 400
Feb 18, 2016 $3.82 $4.35 $3.82 $4.25 958 400
Feb 17, 2016 $3.72 $3.95 $3.72 $3.81 550 800
Feb 16, 2016 $3.78 $3.84 $3.55 $3.64 402 000
Feb 12, 2016 $3.72 $3.77 $3.57 $3.77 328 000
Feb 11, 2016 $3.40 $3.66 $3.30 $3.62 675 200
Feb 10, 2016 $3.83 $3.95 $3.47 $3.50 770 900
Feb 09, 2016 $4.12 $4.40 $3.60 $3.71 1 204 000
Feb 08, 2016 $4.25 $4.40 $4.08 $4.32 978 800
Feb 05, 2016 $4.70 $4.74 $4.52 $4.64 711 900
Feb 04, 2016 $4.37 $4.83 $4.36 $4.74 1 115 700
Feb 03, 2016 $4.25 $4.67 $4.05 $4.45 1 599 800
Feb 02, 2016 $4.00 $4.90 $3.95 $4.27 3 703 200
Feb 01, 2016 $3.60 $3.95 $3.51 $3.89 551 800
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT